Home » Topics » BioWorld Science

BioWorld Science
RSS

HPV vaccine in phase I at Merck & Co.

May 24, 1996

COX-2 inhibitors in clinical trials at Merck & Co.

May 24, 1996

COX-2 inhibitor selected for further study at Searle

May 24, 1996

Crixivan pediatric formulation in development

May 24, 1996

Ciba-Geigy claims matrix metalloproteinase inhibitors

May 24, 1996

Adefovir dipivoxil to enter phase II/III in mid-1996

May 24, 1996

PRO-2000 begins phase I/II in Europe

May 24, 1996

Agouron presents Viracept trial results

May 24, 1996

PMPA: Candidate for clinical study in AIDS

May 24, 1996

Anti-HIV compounds isolated from marine organism

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...